scispace - formally typeset
B

Bo Heng Zhang

Researcher at Fudan University

Publications -  6
Citations -  462

Bo Heng Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 4, co-authored 6 publications receiving 309 citations. Previous affiliations of Bo Heng Zhang include Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

TL;DR: A guideline on the surveillance, diagnosis, staging, and treatment of HCC occurring in China is presented, and recommendations regarding patients with HCC in China are made to ensure optimum patient outcomes.
Journal ArticleDOI

Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma

TL;DR: In intrahepatic cholangiocarcinoma (ICC), the histological maturity of FTS is a robust prognostic indicator for patients who underwent curative resection and the prognostic nomogram constructed on the maturity ofFTS possessed higher predictive power relative to the conventional tumor-node-metastasis staging systems.
Journal Article

Hepatocellular Carcinoma: The Role of Screening.

TL;DR: Alpha-fetoprotein serosurvey plus ultrasonography has been employed as the principal screening approach for early detection of subclinical HCC and has proven to be an important approach to improve overall prognosis, and has also led to changing concepts in clinical research into HCC.
Journal Article

Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma

TL;DR: RFA combined with systemic chemotherapy is safe, and it can reduce the local recurrence of unresectable small hepatocellular carcinoma, as well as other cancer types, through a prospective randomized trial.